Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Meiragtx Holdings Plc (MGTX)

Meiragtx Holdings Plc (MGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 599,658
  • Shares Outstanding, K 80,491
  • Annual Sales, $ 33,280 K
  • Annual Income, $ -147,790 K
  • EBIT $ -164 M
  • EBITDA $ -150 M
  • 60-Month Beta 1.37
  • Price/Sales 21.71
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 639.95% (+17.96%)
  • Historical Volatility 50.10%
  • IV Percentile 99%
  • IV Rank 97.51%
  • IV High 654.36% on 02/10/26
  • IV Low 76.02% on 03/20/25
  • Expected Move (DTE 26) 0.00 (0.00%)
  • Put/Call Vol Ratio 999.99
  • Today's Volume 49
  • Volume Avg (30-Day) 39
  • Put/Call OI Ratio 0.50
  • Today's Open Interest 1,344
  • Open Int (30-Day) 1,137
  • Expected Range 7.45 to 7.45

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.60
  • Number of Estimates 3
  • High Estimate -0.56
  • Low Estimate -0.64
  • Prior Year -0.50
  • Growth Rate Est. (year over year) -20.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.16 +4.02%
on 02/12/26
8.35 -10.72%
on 01/22/26
+0.13 (+1.78%)
since 01/20/26
3-Month
7.00 +6.43%
on 01/12/26
9.50 -21.58%
on 12/12/25
+0.02 (+0.27%)
since 11/20/25
52-Week
4.55 +63.74%
on 05/14/25
9.73 -23.43%
on 11/10/25
+0.62 (+9.08%)
since 02/20/25

Most Recent Stories

More News
ZipBio and MeiraGTx Enter into Exclusive License Agreement to Advance First-in-Class AAV Gene Therapy for Geographic Atrophy

BOSTON , Feb. 3, 2026 /PRNewswire/ -- ZipBio, a biotechnology company pioneering AI-driven protein therapeutics, announced an exclusive license agreement with MeiraGTx Holdings plc (Nasdaq: MGTX),...

MGTX : 7.45 (-1.19%)
Graviton Bioscience to Present Selective ROCK2 Obesity Data at 8th Annual Evercore HealthCONx Conference

NEW YORK , Nov. 20, 2025 /PRNewswire/ -- Graviton Bioscience Corporation, a clinical-stage biotechnology company developing selective ROCK2 inhibitors for metabolic, inflammatory, fibrotic, and...

MGTX : 7.45 (-1.19%)
MeiraGTx Reports Third Quarter 2025 Financial and Operational Results

Entered into broad strategic collaboration with Eli Lilly and Company (“Lilly”) in the area of ophthalmology, granting Lilly worldwide exclusive rights to the Company’s AAV-AIPL1 program for treatment...

MGTX : 7.45 (-1.19%)
MeiraGTx Enters into Strategic Collaboration with Eli Lilly and Company to Develop and Commercialize Genetic Medicines in Ophthalmology

LONDON and NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage genetic medicines company, today announced a broad strategic collaboration...

MGTX : 7.45 (-1.19%)
Evercore ISI Sticks to Its Buy Rating for Meiragtx Holdings (MGTX)

Evercore ISI analyst maintained a Buy rating on Meiragtx Holdings today and set a price target of $25.00. The company’s shares closed yesterday at $8.49.Elevate Your Investing Strategy: Take advantage...

MGTX : 7.45 (-1.19%)
MeiraGTx Announces Two Posters at the European Society of Gene and Cell Therapy (ESGCT) 2025 Annual Congress

LONDON and NEW YORK, Oct. 07, 2025 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical-stage genetic medicines company, today announced the Company will exhibit...

MGTX : 7.45 (-1.19%)
MeiraGTx Reports Second Quarter 2025 Financial and Operational Results

-   Gained alignment with U.S. Food and Drug Administration (FDA) on the ongoing Phase 2 AQUAx2 randomized double-blind, placebo-controlled pivotal study in Grade 2/3 radiation-induced xerostomia (RIX)...

MGTX : 7.45 (-1.19%)
3 Promising Genomics Stocks to Keep an Eye On in 2025

An updated edition of the May 21, 2025, article.The promising field of genomics has undergone rapid evolution over the past decade. Genomics includes the study of a complete set of genes, their work process...

BEAM : 27.59 (-1.04%)
KRYS : 261.80 (-0.33%)
MGTX : 7.45 (-1.19%)
NTLA : 12.64 (-3.07%)
MeiraGTx Announces the Presentation of Four Posters at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual Meeting

MGTX : 7.45 (-1.19%)
MeiraGTx Reports First Quarter 2025 Financial and Operational Results

MGTX : 7.45 (-1.19%)

Business Summary

MeiraGTx Holdings plc focuses on operating as a holding company for MeiraGTx Limited which operates as a clinical stage gene therapy company. It develops novel gene therapy treatments for inherited and acquired disorders. The company's product pipeline consists of AAV-CNGB3, AAV-CNGA3, AAV-RPE65, AAV-RPGR,...

See More

Key Turning Points

3rd Resistance Point 7.84
2nd Resistance Point 7.70
1st Resistance Point 7.58
Last Price 7.45
1st Support Level 7.32
2nd Support Level 7.18
3rd Support Level 7.06

See More

52-Week High 9.73
Fibonacci 61.8% 7.75
Last Price 7.45
Fibonacci 50% 7.14
Fibonacci 38.2% 6.53
52-Week Low 4.55

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar